Featured by Newsweek & World Class Media Outlets

Interviews

Industry

Daniel J. Hicklin, Ph.D.
Daniel J. Hicklin, Ph.D.
Founder, President & CEO
Werewolf Therapeutics
2024-04-18

Our technology was designed to overcome these barriers, enabling the development of cytokine therapies that are activated only within the tumor microenvironment, thereby improving their safety and efficacy.

READ MORE
Jeff Cambra
Jeff Cambra
CEO
SpinaFX
2024-04-17

Our vision extends beyond being just a provider of innovative medical devices; we aspire to be a patient-centric company that enhances patient outcomes and quality of life.

READ MORE
Matthew B. Klein - MD
Matthew B. Klein - MD
CEO
PTC Therapeutics
2024-04-16

For example, our gene therapy for the rare disease AADC deficiency, has allowed children who were previously unable to spontaneously move to begin to lift their heads, crawl, and walk, transforming their lives.

READ MORE
Michael Stubblefield
Michael Stubblefield
CEO
Avantor
2024-04-16

Our offerings include ultra-high purity ingredients and materials that are critical in the development of leading therapies worldwide, for example our products and materials are integral to 85 percent of the top 20 biologic therapies in the market today.

READ MORE
Daniel O’Connell
Daniel O’Connell
CEO
Acumen
2024-04-16

The battle against Alzheimer's disease has reached a pivotal moment.

READ MORE
Dr. David O’Neill
Dr. David O’Neill
President
FACIT
2024-04-16

FACIT's role is to actively compete in the marketplace for IP destinations, fostering a local ecosystem that supports strong company development.

READ MORE
Robert Blum
Robert Blum
President & CEO
Cytokinetics
2024-04-16

Our early dedication to muscle biology positioned us as leaders in this emerging pharmacology. Our strategic focus enabled us to be well positioned as a partner of choice to companies focused to clinical indications adjacent to our own commitments.

READ MORE
Alec Ford
Alec Ford
CEO
Karius
2024-04-16

Over half of all cancer deaths are due to infections, not the cancer itself. In the United States alone, every minute, five cancer patients are admitted to hospitals for infections, leading to nearly a thousand deaths every day.

READ MORE
Andrew Hirsch
Andrew Hirsch
President & CEO
C4 Therapeutics
2024-04-15

Our vision for C4 Therapeutics is to expand and advance our pipeline further into clinical development, with the ultimate goal of bringing transformative treatments to patients. The aspiration to hear a patient attribute their survival to our work is the ultimate validation of our efforts and drives everything we do.

READ MORE
Michael Bronfein
Michael Bronfein
CEO & Co-Founder
Curio Wellness
2024-04-15

Our goal is to ensure Curio Wellness remains a key player by becoming a public company, providing value to both patients and shareholders through our commitment to safe, effective, and reliable products.

READ MORE